Jeff Karp

Jeff Karp is a Co-Founder & Board Observer at TISSIUM. Jeff has also worked as Broad Institute, Landsdowne Labs, TEDMED, Frequency Therapeutics, TISSIUM, Alivio Therapeutics, Partners HealthCare, and Skintifique. Jeff has also worked as Brigham and Women's Hospital.

Jeff Karp completed a PhD in Chemical and Biomedical Engineering at the University of Toronto. Jeff then went on to complete a postdoc in Stem Cells and Advanced Biomaterials at the Massachusetts Institute of Technology. Jeff Karp also holds a BENG in Chemical Engineering from McGill University and has a certification from Scoutible in Strengths Resume.